Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Gilead Faces Lawsuit Over Hepatitis C Drug Pricing

December 11, 2014 1:59 pm | by The Associated Press | News | Comments

Philadelphia's Transportation Authority has filed a lawsuit against Gilead Sciences over the pricing of its hepatitis C drug. Gilead has been selling a 12-week treatment of Sovaldi in the United States for approximately $84,000, or $1,000 per pill.

TOPICS:

FDA Approves Test to Confirm Presence of Human T-cell Lymphotropic Virus-I/II Antibodies

December 11, 2014 1:53 pm | News | Comments

The FDA has approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II). This test is intended for use as an additional, more specific test for human serum or plasma specimens that have previously tested positive on an FDA-licensed HTLV-I/II blood donor screening test.

TOPICS:

New Tool Could Help Prevent the Flu

December 11, 2014 1:48 pm | Videos | Comments

A new website tracks the flu virus by location in an effort to try to prevent infection.                           

TOPICS:
Advertisement

Can We Really Beat Cancer?

December 11, 2014 12:05 pm | Videos | Comments

Oncologist and CBS News medical contributor Dr. David Agus discusses a revolutionary approach for the treatment of cancer which was featured on "60 Minutes."                

TOPICS:

Woman 'Burns' From Inside Out After Reaction to Friend's Meds

December 11, 2014 11:49 am | Videos | Comments

Yassmeen Castanada, 19, is in intensive care after suffering an allergic reaction to a friend's medicine.                        

TOPICS:

High-Pressure Reactor

December 11, 2014 11:40 am | Product Releases | Comments

The HPR-Micro Reactor™ is ideal for early, exploratory research. It is especially well suited for research, process development, and screening applications when reagents, catalysts, or other essential materials are expensive or available in very limited supply.

Health Law Sign-Ups Pick Up

December 11, 2014 10:58 am | News | Comments

The Obama administration says sign-ups picked up last week under the president's health care law. More than 618,000 people selected a plan for 2015 from Nov. 29 through Dec. 5, the Health and Human Services department reported.    

TOPICS:

Swiss Researchers Suspend Ebola Vaccine Trial

December 11, 2014 10:05 am | by The Associated Press | News | Comments

Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. The Hopitaux Universitaires de Geneve said the trial had been suspended "as a precautionary measure." The study involving 59 people began in November.

TOPICS:
Advertisement

Vetter Opens Third Cleanroom for Clinical Syringe Projects

December 11, 2014 9:59 am | News | Comments

Vetter has announced that its U.S. early-stage development site located at the Illinois Science + Technology Park in suburban Chicago, has completed the next step of its expansion with the addition of a third cleanroom. Clinical syringe projects are now being accepted at the facility, which can handle preclinical through phase II projects.

TOPICS:

Milions of Americans Have Unpaid Medical Bills

December 11, 2014 8:21 am | by JOSH BOAK, AP Economics Writer | News | Comments

Nearly 20 percent of U.S. consumers, 42.9 million people, have unpaid medical debts, according to a new report by the Consumer Financial Protection Bureau. The findings suggest that many Americans are being trapped by debt because they are confused by the notices they get from hospitals and insurance companies about the cost of treatment.

TOPICS:

J&J Named Happiest Company to Work For

December 11, 2014 8:15 am | News | Comments

CareerBliss has announced the 5th annual CareerBliss 50 Happiest Companies in America awards list. The list honors the top companies dedicated to creating happier work environments - as voted for by their own employees.     

TOPICS:

Walgreens President and CEO to Retire Following Merger with Alliance Boots

December 10, 2014 4:21 pm | News | Comments

Walgreens announced that Greg Wasson, president and chief executive officer, has informed the company’s board of directors that he will retire shortly after the close of the second step of the Alliance Boots transaction, on which shareholders are scheduled to vote on Dec. 29, 2014.

TOPICS:

New Solutions Boost Flexibility in Pharmaceutical Manufacturing

December 10, 2014 4:03 pm | by Julie Ackerman Montross, Senior Director, PR and Communications, PMMI | Blogs | Comments

Enhancing the flexibility of operations is swiftly becoming a major priority for pharmaceutical manufacturers. In Accenture’s 2013 marketing study of leading manufacturers, 82 percent of respondents agreed “the ability to flexibly and dynamically move product from one facility to another or to change the product mix at an existing facility to match demand is critical to achieving our growth goals.”

TOPICS:

FDA OKs Gardasil 9 to Prevent Cancers Caused by Five Additional Types of HPV

December 10, 2014 3:27 pm | News | Comments

The FDA has approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types of Human Papillomavirus (HPV). Covering nine HPV types, five more HPV types than Gardasil, Gardasil 9 has the potential to prevent approximately 90 percent of cervical, vulvar, vaginal and anal cancers.

TOPICS:

Lawmakers Wary of Genetically Modified Food Labels

December 10, 2014 2:06 pm | by MARY CLARE JALONICK, Associated Press | News | Comments

Republicans and Democrats on a House Energy and Commerce subcommittee questioned Wednesday whether requiring a label on any packaged food including genetically modified organisms — or foods grown from seeds engineered in labs — would be misleading to consumers since there is no evidence that such foods are unsafe.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading